Basiliximab plus low-dose cyclosporin vs. OKT3 for induction immunosuppression following renal transplantation. [electronic resource]
Producer: 20031209Description: 369-76 p. digitalISSN:- 0902-0063
- Antibodies, Monoclonal -- therapeutic use
- Basiliximab
- Cadaver
- Cyclosporine -- therapeutic use
- Drug Therapy, Combination
- Female
- Graft Rejection -- prevention & control
- Graft Survival
- Humans
- Immunosuppressive Agents -- therapeutic use
- Kidney Transplantation
- Male
- Middle Aged
- Muromonab-CD3 -- therapeutic use
- Recombinant Fusion Proteins
No physical items for this record
Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.